Analysis of Direct Costs Associated With the Use of Warfarin in Patients With Atrial Fibrillation

Rational Pharmacotherapy in Cardiology - Russian Federation
doi 10.20996/1819-6446-2011-7-5-561-566
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Related search

Under-Use of Warfarin for Patients With Non-Valvular Atrial Fibrillation in Japan

Internal Medicine
Internal MedicineMedicine
2004English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Prevention of Cardiovascular Outcomes in Diabetic Patients With Atrial Fibrillation: Direct Oral Anticoagulants or Warfarin?

Clinical pharmacology and therapy
2019English

Analysis of Costs of Treatment of Patients With Atrial Fibrillation in the Czech Republic

Cor et Vasa
Cardiovascular MedicineCardiology
2008English

Anticoagulation in Patients With Atrial Fibrillation. Underuse of Warfarin Is Multifactorial.

BMJ
1993English

PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

The Influence of Frailty Under Direct Oral Anticoagulant Use in Patients With Atrial Fibrillation

Heart Asia
Cardiovascular MedicineCardiology
2019English

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

Archives of Internal Medicine
2012English

Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes

Canadian Journal of Kidney Health and Disease
Nephrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy